These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11960595)

  • 1. Chemokines as novel therapeutic targets in inflammatory diseases.
    Ajuebor MN; Swain MG; Perretti M
    Biochem Pharmacol; 2002 Apr; 63(7):1191-6. PubMed ID: 11960595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ; Oostendorp RL; Tak PP
    Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z; Koch AE; Tak PP
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X; Oppenheim JJ; Howard OM
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of chemokine interactions in atherosclerosis.
    Koenen RR; Weber C
    Nat Rev Drug Discov; 2010 Feb; 9(2):141-53. PubMed ID: 20118962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines: their role in rheumatoid arthritis.
    Vergunst CE; Tak PP
    Curr Rheumatol Rep; 2005 Oct; 7(5):382-8. PubMed ID: 16174489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.
    Haringman JJ; Smeets TJ; Reinders-Blankert P; Tak PP
    Ann Rheum Dis; 2006 Mar; 65(3):294-300. PubMed ID: 16107514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming hurdles in developing successful drugs targeting chemokine receptors.
    Schall TJ; Proudfoot AE
    Nat Rev Immunol; 2011 May; 11(5):355-63. PubMed ID: 21494268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines and chemokine receptors in rheumatoid arthritis.
    Szekanecz Z; Kim J; Koch AE
    Semin Immunol; 2003 Feb; 15(1):15-21. PubMed ID: 12495637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of chemokine receptor function.
    Scholten DJ; Canals M; Maussang D; Roumen L; Smit MJ; Wijtmans M; de Graaf C; Vischer HF; Leurs R
    Br J Pharmacol; 2012 Mar; 165(6):1617-1643. PubMed ID: 21699506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical potential of chemokine receptor antagonists.
    Ribeiro S; Horuk R
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemokines in rheumatoid arthritis and osteoarthritis.
    Vergunst CE; van de Sande MG; Lebre MC; Tak PP
    Scand J Rheumatol; 2005; 34(6):415-25. PubMed ID: 16393761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.
    Filer A; Raza K; Salmon M; Buckley CD
    Front Biosci; 2008 Jan; 13():2674-85. PubMed ID: 17981742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor modeling: an interdisciplinary approach to drug design.
    Fricker SP; Metz M
    Future Med Chem; 2014 Jan; 6(1):91-114. PubMed ID: 24358950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses.
    Bhusal RP; Foster SR; Stone MJ
    Protein Sci; 2020 Feb; 29(2):420-432. PubMed ID: 31605402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines and angiogenesis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2001 May; 13(3):202-8. PubMed ID: 11333349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR1 antagonists in clinical development.
    Pease JE; Horuk R
    Expert Opin Investig Drugs; 2005 Jul; 14(7):785-96. PubMed ID: 16022568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery targeting the chemokine system--where are we?
    Horuk R; Proudfoot AE
    Front Biosci (Elite Ed); 2009 Jun; 1(1):209-19. PubMed ID: 19482638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.